Introduction
Mercury and its compounds are environmental pollutants and occupational hazards. The main sources of mercury exposure in the general population are dental amalgam fillings and large consumption of seafood, while occupational exposure may occur in chlor-alkali plants, mercury mines, mercury-based gold extraction, mercury processing and sale, thermometer factories and dental clinics 1) . Mercury ions (Hg 2+ ) can induce a variety of immunopathological disorders 2) . Impaired function of thymus, one of the target organs, is found in mercury intoxication [3] [4] [5] .
The thymus plays an important role in the development of the immune system, particularly in T lymphocyte differentiation and maturation 6) . Thymic epithelial cells secrete thymulin, a zinc-dependent nonapeptide hormone with a large role in immune regulation 7) , whose production declines during chronic inflammation and ageing 8, 9) . Hg 2+ impairs active thymulin production both in vitro and in vivo 10, 11) , possibly due to inhibition of protein synthesis 12) and to a mechanism involving direct substitution of zinc with Hg 2+ in thymulin molecules, resulting in reduced hormone activity 5, 13, 14) .
In a previous study, we described a relationship between thymulin and the vasodilating gas nitric oxide (NO) 9) . NO is generated from the terminal guanidino nitrogen of L-arginine via an oxidative process catalyzed by nitric oxide synthase (NOS). The NOS inhibitor, L-NAME (N G -nitro-L-arginine methyl ester), efficiently reduces thymulin secretion, an effect that is reversed by L-arginine 15) . This essential amino acid restores active thymulin levels impaired by Hg 2+ exposure 5, 11) . Since Hg 2+ reduces NO production 16, 17) likely due to its toxic effect on NOS 17, 18) , and L-arginine acts via the NO pathway 5) , the amino acid supplementation could become a novel strategy to treat inorganic mercury intoxication in the workplace.
Metallothioneins (MTs) are a class of proteins involved in heavy metal detoxification and in the metabolic regulation of essential metals such as zinc and copper. They are low-molecular-weight proteins with 61 amino acids (of which 20 are cysteines) with a high affinity for metals 19) , and play a pivotal role in metal-related cell homeostasis by storing and releasing essential metals and curbing free metal concentrations 20) . MTs have a central role in mercury detoxification 20, 21) and a direct relationship with NO; metal release occurs via an S-nitrosylation reaction 22) . Changes in thymus function induced by L-arginine supplementation during Hg 2+ exposure have been described 5) .
In this study the pivotal role of L-arginine in mercury detoxification was studied in mice treated with two doses of inorganic mercury with and without L-arginine supplementation after one month of Hg 2+ treatment and after one month of wash-out. Mice receiving only injections of saline were used as controls. Thymulin levels and thymus weight to body weight ratio were used as generic measures of thymic function. Mercury thymus content, NOS activity, NO and MTs were analyzed.
Materials and Methods

Animal care and handling
Three-month-old male BALB/C mice (Iffacredo, Orléans, France) housed two-three per cage at 21˚C in a 12 h light/dark cycle with ad libitum access to pellet food and water were randomly assigned to the treatment groups. Food and water consumption and body weight (b.w.) gain were recorded daily ( Table 1 ). The choice of this strain was based on previous works showing the susceptibility of its thymic endocrine efficiency to mercury exposure 11) . Animal care and treatment were in accordance with Public Health Service Policy on the Humane Care and Use of Laboratory Animals guidelines and were approved by the institutional Animal Care and Use Committee 23) .
Treatments
Mice received either 0.001 mg/kg b.w. or 1.0 mg/kg b.w. of HgCl 2 by subcutaneous injection (100 µl every three days) for 30 d; during this time 1.4 × 10 -3 g/d Larginine was added to the purified drinking water. Mice were divided into 7 groups of 8 animals: two mercury groups (high-and low-dose Hg); two mercury and L-arginine groups (high-and low-dose Hg+Arg); wash-out (the two Hg+Arg groups were also studied one month after treatment withdrawal) and a control group (Ctrl) which received injections of saline. Mice were sacrificed at the end of the 30-d treatment by ether anaesthesia using a glass bell. The wash-out group was allowed to survive a further month.
Mercury doses were those used in a previous work 5) .
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Industrial Health 2008, 46, 567-574 Animals were weighed before treatment and immediately after euthanasia. Thymuses were collected, weighed, rapidly frozen in liquid nitrogen and stored at -70˚C until use. Heparinized blood samples were collected into fluorinated tubes (no. 115317, LP, Italy) and centrifuged after 20 min at 3,000 × g for 30 min. Plasma was stored at -70˚C until use. All tests were performed in blind.
Mercury concentration in thymus
Tissues were homogenized in Cytobuster protein extraction reagent (Novagen, Madison, WI, USA) according to the manufacturer's instructions. Mercury concentrations in whole tissue lysates were determined using a Thermo XII Series ICP-MS (Thermo Electron Corporation, Waltham, MA, USA). Samples were appropriately diluted (minimum 1:10) with a diluent containing 0.1% Triton X 100 to stabilize the emulsion and 0.15% HNO 3 to ensure that trace elements were maintained in solution and to favour their wash-out between samples. Multi-element solutions containing Hg 2+ (blank to 2,000 ppb) for external calibration were prepared by serial dilution of a parent multi-element solution (100 ppm for Hg 2+ ) (VHG Labs, Manchester, NH, USA) with the same diluent used for the samples; 200 ng/ml rhodium (Rh) was used as the internal standard. Data were acquired for Hg 202 and Hg 200 .
The instrument was operated with a Peltier cooled impact bead spray chamber, single piece quartz torch (1.5 mm i.d. injector) together with Xi interface cones and a Cetac-ASX 100 autosampler (CETAC Technologies, Omaha, NE, USA).
A Trace nebulizer (Burgener Research Inc., Ontario, Canada) was used as this device does not block during aspiration of clinical samples. The instrument was operated in standard mode (non-CCT), using 1,400 W RF power, 1.10 L min -1 nebulizer gas flow, 0.70 L min -1 auxiliary gas flow, 13.0 L min -1 cool gas flow, 70 ms dwell time, 30 s sample uptake and 35 s wash time (2 repeats per sample).
Thymulin determination
This assay, extensively described elsewhere 24) , is based on the ability of thymulin to restore the inhibitory effect of azathioprine on the formation of spleen T-cell rosettes from young thymectomized mice. The azathioprine sensitivity of T cells closely depends on thymic endocrine function: thymus removal in mice induces complete disappearance of azathioprine sensitivity, that is restored by addition of purified thymulin. This phenomenon is at the basis of the thymulin bioassay in biological fluids 25) . The technique is specific for zinc-bound, active thymulin (ZnFTS), because the other thymic hormones do not affect the assay and the rosette-inducing activity is completely abolished by passing supernatants through an antithymulin immunoadsorbent. Results are expressed as log -2 of the reciprocal maximal supernatant dilution that induces the phenomenon 24) .
NOS activity determination
NOS activity was determined in thymic tissue as the rate of conversion of L-[ 3 H]arginine to L-[ 3 H]citrulline 26, 27) using the Nitric Oxide Synthase Assay Kit (Calbiochem, San Diego, CA, USA). Frozen thymuses were homogenized in 100 µl/mg tissue of ice-cold buffer containing 25 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, and 0.5% of a protease inhibitor cocktail (Sigma, St Louis, MO, USA) and centrifuged at full speed for 5 min at 4˚C. The supernatants were collected and protein content was measured.
Subsequently, 40 µl of a solution containing 31.25 mM Tris-HCl (pH 7.4), 3.75 µM tetrahydrobiopterin, 1.25 µM FAD, 1.25 µM FMN, 12.5% NADPH 10 mM in Tris-HCl 10 mM (pH 7.4) and 2.5% of L-[2,3-3 H]arginine monohydrochloride (0.9 mCi/ml) (Sigma) was added to 10 µl of the supernatant. The NOS inhibitor L-NAME was added to a separate supernatant aliquot to obtain the relative blank. After incubation at 37˚C for 60 min the reaction was stopped by adding a solution containing 50 mM HEPES (pH 5.5), and 5 mM EDTA. An equilibrated resin that binds unreacted L-[ 3 H]arginine was added to the samples before centrifugation at 14,000 rpm for 30 s. A TRI-CARB 2100TR scintillation chamber (Packard Instruments, Meriden, CT, USA) was used to determine L-[ 3 H]citrulline. NOS activity was calculated by subtracting the radioactivity of the blank from that of the sample. Results were expressed as CPM/µg of protein.
Plasma NO determination
Since NO itself is unstable, with a half-life of only 2-3 s in plasma, NO levels were determined from measurement of its stable end-products, nitrate and nitrite (NOx) 28) . NOx were analyzed with Griess reaction in plasma from all mice 29) . Samples, in duplicate, were ultrafiltered through a 10-kDa molecular weight Millipore filter and exposed to 250 mU/ml nitrate reductase and 100 µM NADPH for 4 h at 37˚C to reduce nitrate to nitrite. They were then mixed (1:1) with freshly prepared Griess reagent (0.1% naphthyl-ethylenediamine dihydrochloride in H 2 O + 1% sulphanilamide in 5% H 2 PO 4 ) in flat-bottomed 96-well microtiter immunoassay plates and incubated for 10 min at room temperature. Absorbance of the wells was measured at 538 nm in a micro ELISA reader (Wallac 1420 Victor 2 TM multilabel counter, Perkin Elmer, Waltham, MA, USA). NOx levels in samples were determined using a calibration curve generated with standard NaNO 3 solutions.
RNA extraction and metallothionein RT-PCR
Total RNA was isolated from thymus tissue using Trireagent (Sigma) according to the manufacturer's instructions. RNA purity and concentration were determined at 260 nm and 280 nm using an UV spectrophotometer (Scientific Instruments UV1601 Shimadzu, Columbia, MD, USA). The OD260/OD280 ratio of all RNA samples used was >1.9. Expression of MT isoform I (MT-I) mRNA was assessed by RT-PCR, since during metal intoxication isoforms I and II are the most responsive and are co-ordinately overexpressed 30) . cDNA was synthesized by incubating 3 µg total RNA with 0.5 mM dNTP, 150 ng random nonamers, 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, M-MLV reverse transcriptase (20 U/µl) and RNase Inhibitor (1 U/µl) in a 20 µl final volume. cDNA was frozen at -20˚C until use. PCR was performed as follows: 4 µl cDNA was added to a reaction mixture containing 100 µM dNTP, specific MT-I sense ATGGACCCCAACTGCTCCTGCTCCACC and antisense GGGTGGAACTGTATAGGAAGA primers, and 0.02 U/µl AccuTaq LA DNA polymerase in a 50 µl total volume. Samples were incubated in a GeneAmp PCR System 9700 (Perkin Elmer) in the following conditions (36 cycles): denaturation at 94˚C for 30 s, annealing at 50˚C for 30 s, and extension at 72˚C for 1 min. The housekeeping gene β-actin cDNA was amplified using specific sense GGACTCC-TATGTGGGTGACGAGG and antisense GGGAGAG-CATAGCCCTCGTAGAT primers under the following conditions (30 cycles): denaturation at 94˚C for 1 min, annealing at 61˚C for 1 min and extension at 72˚C for 1 min. All primers were from Roche Diagnostics (GmbH, Mannheim, Germany). PCR amplification products were separated by 2% agarose gel electrophoresis containing 1 µg/ml ethidium bromide, visualized with UV light and photographed on Polaroid type 667 positive film. The intensity of the 259 bp and 366 bp bands for MT-I and β-actin, respectively, was measured by densitometry using Gel Doc 2000 (Bio-Rad Laboratories, Richmond, CA, USA). Results were expressed as MT-I/β-actin ratio.
Statistical analysis
Among-groups differences were tested with one-way ANOVA and between-groups differences with unpaired Student t test. Survival differences were analyzed with the χ 2 test. Significance was established at p<0.05.
Results
Exposure to mercuric chloride affected weight gain (Table 1 ). Mice treated with the higher HgCl 2 dose (1.0 mg/kg) lost 2.1 g of b.w. compared with a gain of 2.4 g in control mice (p<0.001), while the weight gain of animals exposed to the lower dose (0.001 mg/kg) was not significantly different from that of control mice. Hg+Arg mice receiving the higher HgCl 2 dose lost significantly less (p<0.05) weight than the corresponding Hg group. Survival was not significantly different among groups, even though 37% of mice treated with high-dose Hg 2+ alone died. The thymus weight: body weight ratio was similar in all groups. Thymulin was significantly (p<0.05) reduced in both Hg groups compared with controls. In the groups receiving L-arginine (Hg+Arg mice) thymulin was similar to the value measured in control mice and significantly different (p<0.05) from the values found in the Hg groups (Fig. 1) .
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Thymus NOS activity and NO production were decreased in the Hg groups (Fig. 2) . Both measures were significantly higher (p<0.05) in Hg+Arg mice than in the respective Hg groups. Expression of whole-thymus MT-I mRNA was significantly (p<0.05) greater in the Hg (Fig. 3 ) than in the Hg+Arg groups. Values in wash-out mice were not significantly different for any parameter, except for significantly higher (p<0.01) MT-I expression in the animals treated with the higher Hg 2+ dose compared with the value at the end of treatment (Hg+Arg).
Discussion
Since mercury ions have a high affinity for sulfhydrylcontaining molecules such as cysteine (Cys) 31) , Hg 2+ in mercury-exposed thymus is believed to bind to Cys-rich MT-I and to accumulate in the organ 20) . Indeed, MT-I mRNA expression in whole thymus was significantly raised in mice exposed to both Hg 2+ doses. Accumulation of Hg 2+ in thymus epithelial cells causes cytotoxicity, disrupting thymulin production and function 5) . Decreased NOS activity could thus be a consequence of Hg 2+ -induced toxicity 17) . In addition, there appeared to be a dynamic interaction between Hg 2+ and Zn 2+ . Inorganic mercury can be scavenged by MTs, with concomitant zinc release from the same domain. Released zinc can suppress NOS activity 22, 32) . Some nutritional factors have been shown to modulate mercury toxicity, in particular alpha-lipoic acid, N-acetylcysteine, glutathione, zinc and selenium 33, 34) . L-arginine induces a range of beneficial immunological effects 5) . Thymulin was significantly higher in the Hg+Arg than in the Hg groups, with values comparable to those of control mice, and was not significantly different in the washout group, reflecting the stable benefits of L-arginine administration.
Mice in both Hg+Arg groups accumulated less inorganic mercury in the organ, they were healthy, their weight gain was unaffected and their survival was similar to that of untreated mice. Such reduced accumulation of mercury, which was accompanied by increased NOS activity (hence NO production) due to L-arginine administration, could be related to NO-MT s interactions leading to nitrosylation and metal release 22) .
One month from Hg 2+ withdrawal, mercury thymus content, thymulin, NOS activity and NO production were not significantly different in the wash-out group, except for a significantly higher MT-I expression in mice exposed to the higher Hg 2+ dose compared with the value measured at the end of treatment. Further studies are required to elucidate the mechanism underpinning such elevated MT-I expression. One explanation may be the inflammatory state associated with mercury exposure 35) . The Hg 2+ still present in the high-dose Hg+Arg wash-out group, no longer controlled by L-arginine, may also be responsible for a rebound of the inflammatory state, which was not investigated in this study but which can increase MTs expression 36) . Local zinc distribution and levels in cells may also play a pivotal role 37) .
This study demonstrates the potential of L-arginine as a therapeutic strategy against occupational or environmental exposure to inorganic mercury. Current treatments, introduced more than 30 yr ago, consist of mercury-chelating drugs; their utilization is increasingly frequent, despite rare but potentially severe side-effects and the lack of controlled studies showing that chelating therapy actually improves outcome [38] [39] [40] . Chelating therapy, based on Hg 2+ binding, is used mostly in subjects with acute intoxication. L-arginine, whose action mechanism involves the NO pathway, could be also used in low-level chronic exposure. Further researches are required to confirm the safety and efficacy of L-arginine supplementation against mercury exposure. The present findings, the evidence against any adverse effects of L-arginine in healthy human adults 41) , its free commercial availability and low cost make L-arginine supplementation a potentially valuable preventive or therapeutic strategy against occupational or environmental exposure to inorganic mercury. 
